Transcriptional repression of ifn regulatory factor 7 by myc is critical for type i ifn production in human plasmacytoid dendritic cells

Tae Whan Kim, Seunghee Hong, Yin Lin, Elise Murat, HyeMee Joo, Taeil Kim, Virginia Pascual, Yong Jun Liu

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Type I IFNs are crucial mediators of human innate and adaptive immunity and are massively produced from plasmacytoid dendritic cells (pDCs). IFN regulatory factor (IRF)7 is a critical regulator of type I IFN production when pathogens are detected by TLR 7/9 in pDC. However, hyperactivation of pDC can cause life-threatening autoimmune diseases. To avoid the deleterious effects of aberrant pDC activation, tight regulation of IRF7 is required. Nonetheless, the detailed mechanisms of how IRF7 transcription is regulated in pDC are still elusive. MYC is a well-known highly pleiotropic transcription factor; however, the role of MYC in pDC function is not well defined yet. To identify the role of transcription factor MYC in human pDC, we employed a knockdown technique using human pDC cell line, GEN2.2. When we knocked down MYC in the pDC cell line, production of IFN-stimulated genes was dramatically increased and was further enhanced by the TLR9 agonist CpGB. Interestingly, MYC is shown to be recruited to the IRF7 promoter region through interaction with nuclear receptor corepressor 2/histone deacetylase 3 for its repression. In addition, activation of TLR9-mediated NF-kB and MAPK and nuclear translocation of IRF7 were greatly enhanced by MYC depletion. Pharmaceutical inhibition of MYC recovered IRF7 expression, further confirming the negative role of MYC in the antiviral response by pDC. Therefore, our results identify the novel immunomodulatory role of MYC in human pDC and may add to our understanding of aberrant pDC function in cancer and autoimmune disease.

Original languageEnglish (US)
Pages (from-to)3348-3359
Number of pages12
JournalJournal of Immunology
Volume197
Issue number8
DOIs
StatePublished - Oct 15 2016
Externally publishedYes

Fingerprint

Dendritic Cells
Autoimmune Diseases
Transcription Factors
Cell Line
Co-Repressor Proteins
NF-kappa B
Adaptive Immunity
Innate Immunity
Genetic Promoter Regions
Antiviral Agents
Pharmaceutical Preparations
Genes
Neoplasms

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Transcriptional repression of ifn regulatory factor 7 by myc is critical for type i ifn production in human plasmacytoid dendritic cells. / Kim, Tae Whan; Hong, Seunghee; Lin, Yin; Murat, Elise; Joo, HyeMee; Kim, Taeil; Pascual, Virginia; Liu, Yong Jun.

In: Journal of Immunology, Vol. 197, No. 8, 15.10.2016, p. 3348-3359.

Research output: Contribution to journalArticle

Kim, Tae Whan ; Hong, Seunghee ; Lin, Yin ; Murat, Elise ; Joo, HyeMee ; Kim, Taeil ; Pascual, Virginia ; Liu, Yong Jun. / Transcriptional repression of ifn regulatory factor 7 by myc is critical for type i ifn production in human plasmacytoid dendritic cells. In: Journal of Immunology. 2016 ; Vol. 197, No. 8. pp. 3348-3359.
@article{251a5d960b6546809a66e2d35ce90c85,
title = "Transcriptional repression of ifn regulatory factor 7 by myc is critical for type i ifn production in human plasmacytoid dendritic cells",
abstract = "Type I IFNs are crucial mediators of human innate and adaptive immunity and are massively produced from plasmacytoid dendritic cells (pDCs). IFN regulatory factor (IRF)7 is a critical regulator of type I IFN production when pathogens are detected by TLR 7/9 in pDC. However, hyperactivation of pDC can cause life-threatening autoimmune diseases. To avoid the deleterious effects of aberrant pDC activation, tight regulation of IRF7 is required. Nonetheless, the detailed mechanisms of how IRF7 transcription is regulated in pDC are still elusive. MYC is a well-known highly pleiotropic transcription factor; however, the role of MYC in pDC function is not well defined yet. To identify the role of transcription factor MYC in human pDC, we employed a knockdown technique using human pDC cell line, GEN2.2. When we knocked down MYC in the pDC cell line, production of IFN-stimulated genes was dramatically increased and was further enhanced by the TLR9 agonist CpGB. Interestingly, MYC is shown to be recruited to the IRF7 promoter region through interaction with nuclear receptor corepressor 2/histone deacetylase 3 for its repression. In addition, activation of TLR9-mediated NF-kB and MAPK and nuclear translocation of IRF7 were greatly enhanced by MYC depletion. Pharmaceutical inhibition of MYC recovered IRF7 expression, further confirming the negative role of MYC in the antiviral response by pDC. Therefore, our results identify the novel immunomodulatory role of MYC in human pDC and may add to our understanding of aberrant pDC function in cancer and autoimmune disease.",
author = "Kim, {Tae Whan} and Seunghee Hong and Yin Lin and Elise Murat and HyeMee Joo and Taeil Kim and Virginia Pascual and Liu, {Yong Jun}",
year = "2016",
month = "10",
day = "15",
doi = "10.4049/jimmunol.1502385",
language = "English (US)",
volume = "197",
pages = "3348--3359",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "8",

}

TY - JOUR

T1 - Transcriptional repression of ifn regulatory factor 7 by myc is critical for type i ifn production in human plasmacytoid dendritic cells

AU - Kim, Tae Whan

AU - Hong, Seunghee

AU - Lin, Yin

AU - Murat, Elise

AU - Joo, HyeMee

AU - Kim, Taeil

AU - Pascual, Virginia

AU - Liu, Yong Jun

PY - 2016/10/15

Y1 - 2016/10/15

N2 - Type I IFNs are crucial mediators of human innate and adaptive immunity and are massively produced from plasmacytoid dendritic cells (pDCs). IFN regulatory factor (IRF)7 is a critical regulator of type I IFN production when pathogens are detected by TLR 7/9 in pDC. However, hyperactivation of pDC can cause life-threatening autoimmune diseases. To avoid the deleterious effects of aberrant pDC activation, tight regulation of IRF7 is required. Nonetheless, the detailed mechanisms of how IRF7 transcription is regulated in pDC are still elusive. MYC is a well-known highly pleiotropic transcription factor; however, the role of MYC in pDC function is not well defined yet. To identify the role of transcription factor MYC in human pDC, we employed a knockdown technique using human pDC cell line, GEN2.2. When we knocked down MYC in the pDC cell line, production of IFN-stimulated genes was dramatically increased and was further enhanced by the TLR9 agonist CpGB. Interestingly, MYC is shown to be recruited to the IRF7 promoter region through interaction with nuclear receptor corepressor 2/histone deacetylase 3 for its repression. In addition, activation of TLR9-mediated NF-kB and MAPK and nuclear translocation of IRF7 were greatly enhanced by MYC depletion. Pharmaceutical inhibition of MYC recovered IRF7 expression, further confirming the negative role of MYC in the antiviral response by pDC. Therefore, our results identify the novel immunomodulatory role of MYC in human pDC and may add to our understanding of aberrant pDC function in cancer and autoimmune disease.

AB - Type I IFNs are crucial mediators of human innate and adaptive immunity and are massively produced from plasmacytoid dendritic cells (pDCs). IFN regulatory factor (IRF)7 is a critical regulator of type I IFN production when pathogens are detected by TLR 7/9 in pDC. However, hyperactivation of pDC can cause life-threatening autoimmune diseases. To avoid the deleterious effects of aberrant pDC activation, tight regulation of IRF7 is required. Nonetheless, the detailed mechanisms of how IRF7 transcription is regulated in pDC are still elusive. MYC is a well-known highly pleiotropic transcription factor; however, the role of MYC in pDC function is not well defined yet. To identify the role of transcription factor MYC in human pDC, we employed a knockdown technique using human pDC cell line, GEN2.2. When we knocked down MYC in the pDC cell line, production of IFN-stimulated genes was dramatically increased and was further enhanced by the TLR9 agonist CpGB. Interestingly, MYC is shown to be recruited to the IRF7 promoter region through interaction with nuclear receptor corepressor 2/histone deacetylase 3 for its repression. In addition, activation of TLR9-mediated NF-kB and MAPK and nuclear translocation of IRF7 were greatly enhanced by MYC depletion. Pharmaceutical inhibition of MYC recovered IRF7 expression, further confirming the negative role of MYC in the antiviral response by pDC. Therefore, our results identify the novel immunomodulatory role of MYC in human pDC and may add to our understanding of aberrant pDC function in cancer and autoimmune disease.

UR - http://www.scopus.com/inward/record.url?scp=84991475053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991475053&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1502385

DO - 10.4049/jimmunol.1502385

M3 - Article

VL - 197

SP - 3348

EP - 3359

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 8

ER -